Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients? [PDF]
ESC Heart Failure, 2023 Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority ...
Alexandru Achim +5 more
doaj +4 more sources
TAVI-in-TAVI in a patient after alcohol septal ablation [PDF]
Advances in Interventional Cardiology, 2021 Cardiovascular medicine at its beginning was dominated by surgical treatment options. The trend of the last decades is heading towards catheterization procedures.
Eva Polaková +3 more
doaj +5 more sources
Alcohol septal ablation therapy for HOCM patients
Indian Heart Journal, 2015 B. Jai Bharat +7 more
doaj +4 more sources
Septal alcohol ablation and Heyde's syndrome revisited [PDF]
Journal of Internal Medicine, 2003 Abstract. Riis Hansen P, Hassager C (Gentofte University Hospital, Hellerup, Denmark). Septal alcohol ablation and Heyde's syndrome revisited. (Case Report). J Intern Med 2003; 253: 490–491.We describe a 57‐year‐old male with hypertrophic obstructive cardiomyopathy and occult blood loss.
Peter Riis Hansen, Christian Hassager
openalex +4 more sources
Hypertrophic obstructive cardiomyopathy with left ventricle outflow tract chordae insertion: Surgery or alcohol septal ablation? A case report [PDF]
Clinical Case Reports, 2023 Key Clinical Message Anomalous insertion of chordae is a rare disease that could be associated with hypertrophic obstructive cardiomyopathy (HOCM), but clinical and echocardiographic diagnoses tend to be delayed. Alcohol septal ablation has emerged as an
Rania Hammami +5 more
doaj +2 more sources
Glue septal ablation: A promising alternative to alcohol septal ablation [PDF]
JRSM Cardiovascular Disease, 2016 Hypertrophic cardiomyopathy (HCM) is defined as myocardial hypertrophy in the absence of another cardiac or systemic disease capable of producing the magnitude of present hypertrophy. In about 70% of patients with HCM, there is left ventricular outflow tract (LVOT) obstruction (LVOTO) and this is known as obstructive type of hypertrophic ...
Sercan Okutucu +2 more
openalex +5 more sources
Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center Experience [PDF]
Anatolian Journal of Cardiology, 2022 Background: Alcohol septal ablation is recommended for hypertrophic obstructive cardiomyopathy patients who had refractory symptoms despite optimal medical treatment.
Umut Karabulut +5 more
doaj +2 more sources
Alternative ‘block and delivery’ approach for alcohol septal ablation in hypertrophic cardiomyopathy with ischemia: a case report [PDF]
The Egyptian Heart JournalBackground Hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder characterized by marked myocardial hypertrophy, which may lead to impaired diastolic function and relative myocardial ischemia.
S. M. Mamun Iqbal +6 more
doaj +2 more sources
Alcohol septal ablation – An evolving procedure
Indian Heart Journal, 2012 Alcohol septal ablation was first reported by Sigwart in 1985.1 Since then the use of this procedure has increased exponentially and today the number of alcohol ablations performed far exceed that of surgical myectomy.2 Alcohol septal ablation has been reported from Indian centres since the mid-1990s.3 ...
Ajay Bahl
doaj +3 more sources
Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy. [PDF]
J Clin Med, 2023 Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by an increased left ventricular wall thickness in the absence of increased afterload conditions. In addition to diastolic dysfunction, obstruction of the left ventricular outflow tract is common in HCM and has an important influence on symptoms and outcome. Over the last five decades
Scholtz S, Rudolph V, Reil JC.
europepmc +4 more sources